Substance P Modulation of Human and Murine Corneal Neovascularization.

Purpose The purpose of this study was to investigate the role of substance P (SP) in patients affected with corneal neovascularization (CNV) and in three different Tac1-knockout (KO) murine models of CNV. Methods SP levels in tears were measured with a multiplex bead assay. The extent of human CNV was quantified as number of affected corneal quadrants. Murine CNV was induced in both strains by means of total disepithelization, alkali burn, and intrastromal sutures. After death, CNV (blood and lymphatic) and leukocyte infiltration were quantified by CD31, LYVE1, and CD45 immunofluorescence, respectively. Trigeminal ganglions were collected for quantitatitive PCR IL1β quantification. Hematoxylin-eosin corneal cross sections and whole-mounted β-3-tubulin nerve staining were used to compare anatomy and nerve density of wild-type (WT) versus Tac1-KO normal mice. Results SP tear levels correlate positively with CNV extension in patients (r = 0.49, P = 0.03). After disepithelization, Tac1-KO corneas showed reduced blood and lymphatic vascularization (-34% and -51% respectively) compared with the WT counterpart. CD45+ leukocytes infiltrating the cornea were reduced in Tac1-KO mice as opposed to WT in the disepithelization (P = 0.0001), alkali burn (P = 0.0258), and suture (P = 0.0149) models. Tac1-KO mice showed reduced IL1β expression in the trigeminal ganglion. Normal WT and Tac1-KO corneas did not show significant differences in transparency, thickness, and nerve density. Conclusions Our results suggest (1) the involvement of SP in human CNV; (2) the key role of SP in promoting inflammatory CNV in three different mouse models; and (3) that absence of SP is not associated with obvious ocular surface pathology in a KO model.

[1]  S. Swamynathan,et al.  Inhibition of HUVEC tube formation via suppression of NF&kgr;B suggests an anti‐angiogenic role for SLURP1 in the transparent cornea , 2017, Experimental eye research.

[2]  P. Rama,et al.  Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment , 2017, Acta ophthalmologica.

[3]  P. Stuart,et al.  Understanding the Role of Chemokines and Cytokines in Experimental Models of Herpes Simplex Keratitis , 2017, Journal of immunology research.

[4]  J. F. Gomez-Sosa,et al.  Angiogenic mechanisms of human dental pulp and their relationship with substance P expression in response to occlusal trauma , 2017, International endodontic journal.

[5]  S. Douglas,et al.  Substance P–mediated chemokine production promotes monocyte migration , 2017, Journal of leukocyte biology.

[6]  Jiucheng He,et al.  Neuroanatomy and Neurochemistry of Mouse Cornea , 2016, Investigative ophthalmology & visual science.

[7]  M. Słoniecka,et al.  Substance P Enhances Keratocyte Migration and Neutrophil Recruitment through Interleukin-8 , 2016, Molecular Pharmacology.

[8]  P. Gascón,et al.  Biological and Pharmacological Aspects of the NK1-Receptor , 2015, BioMed research international.

[9]  M. Słoniecka,et al.  Expression Profiles of Neuropeptides, Neurotransmitters, and Their Receptors in Human Keratocytes In Vitro and In Situ , 2015, PloS one.

[10]  J. Niederkorn,et al.  Severing Corneal Nerves in One Eye Induces Sympathetic Loss of Immune Privilege and Promotes Rejection of Future Corneal Allografts Placed in Either Eye , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  P. Rama,et al.  NK1 receptor antagonists as a new treatment for corneal neovascularization. , 2014, Investigative ophthalmology & visual science.

[12]  G. Comi,et al.  Ocular surface injury induces inflammation in the brain: in vivo and ex vivo evidence of a corneal-trigeminal axis. , 2014, Investigative ophthalmology & visual science.

[13]  Lixin Xie,et al.  Substance P Promotes Diabetic Corneal Epithelial Wound Healing Through Molecular Mechanisms Mediated via the Neurokinin-1 Receptor , 2014, Diabetes.

[14]  T. Chikama,et al.  Neuropeptides released from trigeminal neurons promote the stratification of human corneal epithelial cells. , 2014, Investigative ophthalmology & visual science.

[15]  P. Hamrah,et al.  Corneal Allograft Rejection: Immunopathogenesis to Therapeutics , 2013, Journal of clinical & cellular immunology.

[16]  R. Dana,et al.  Corneal innervation as a window to peripheral neuropathies. , 2013, Experimental eye research.

[17]  K. Maruyama,et al.  Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases , 2013, Progress in Retinal and Eye Research.

[18]  P. Rama,et al.  Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring. , 2013, Investigative ophthalmology & visual science.

[19]  L. Coppola,et al.  Analysis of nerve supply pattern in human lymphatic vessels of young and old men. , 2012, Lymphatic research and biology.

[20]  C. Joo,et al.  Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. , 2012, Investigative ophthalmology & visual science.

[21]  R. Dana,et al.  Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). , 2012, The ocular surface.

[22]  R. Channappanavar,et al.  Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions. , 2011, Investigative ophthalmology & visual science.

[23]  R. Lavker,et al.  Limbal fibroblast conditioned media: A non-invasive treatment for limbal stem cell deficiency , 2011, Molecular vision.

[24]  D. Zawieja,et al.  Substance P Activates Both Contractile and Inflammatory Pathways in Lymphatics Through the Neurokinin Receptors NK1R and NK3R , 2011, Microcirculation.

[25]  Dexter L. Lee,et al.  Role of IL-6 in angiotensin II-induced retinal vascular inflammation. , 2010, Investigative ophthalmology & visual science.

[26]  S. Wiegand,et al.  Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation , 2009, The Journal of Immunology.

[27]  J. Lowe,et al.  Architecture and distribution of human corneal nerves , 2009, British Journal of Ophthalmology.

[28]  M. Skobe,et al.  Blocking the path of lymphatic vessels , 2009, Nature Medicine.

[29]  C. Irwin,et al.  Neuropeptides regulate expression of angiogenic growth factors in human dental pulp fibroblasts. , 2009, Journal of endodontics.

[30]  T. Chikama,et al.  Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy , 2008, British Journal of Ophthalmology.

[31]  W. Fokkens,et al.  Modulation of neurotrophin and neurotrophin receptor expression in nasal mucosa after nasal allergen provocation in allergic rhinitis , 2008, Allergy.

[32]  S. Benemei,et al.  The concept of neurogenic inflammation , 2008, BJU international.

[33]  K. Bartz-Schmidt,et al.  Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn , 2007, Acta ophthalmologica.

[34]  D. Sellami,et al.  Epidemiology and risk factors for corneal graft rejection. , 2007, Transplantation proceedings.

[35]  Claus Cursiefen,et al.  Immune privilege and angiogenic privilege of the cornea. , 2007, Chemical immunology and allergy.

[36]  D. Walsh,et al.  Tachykinins and the cardiovascular system. , 2006, Current drug targets.

[37]  D. Sanders,et al.  The Effect of Combinations of Flurbiprofen, Low Molecular Weight Heparin, and Doxycycline on the Inhibition of Corneal Neovascularization , 2006, Cornea.

[38]  B. Seitz,et al.  Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. , 2006, American journal of ophthalmology.

[39]  F. Shanahan,et al.  The role of substance P in inflammatory disease , 2004, Journal of cellular physiology.

[40]  T. Nishida,et al.  Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. , 2003, Investigative ophthalmology & visual science.

[41]  Claus Cursiefen,et al.  Corneal Lymphangiogenesis: Evidence, Mechanisms, and Implications for Corneal Transplant Immunology , 2003, Cornea.

[42]  Paul H. Black,et al.  Stress and the inflammatory response: A review of neurogenic inflammation , 2002, Brain, Behavior, and Immunity.

[43]  J. D. Richardson,et al.  Cellular Mechanisms of Neurogenic Inflammation , 2002, Journal of Pharmacology and Experimental Therapeutics.

[44]  B. Kirchhof,et al.  Inhibition of inflammatory corneal angiogenesis by TNP-470. , 2001, Investigative ophthalmology & visual science.

[45]  M. T. Tran,et al.  Substance P differentially stimulates IL-8 synthesis in human corneal epithelial cells. , 2000, Investigative ophthalmology & visual science.

[46]  J. Laissue,et al.  Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs. , 1998, Blood.

[47]  P. Holzer Implications of Tachykinins and Calcitonin Gene-Related Peptide in Inflammatory Bowel Disease , 1998, Digestion.

[48]  C. Murphy,et al.  [Neurotrophic keratopathy--studies on substance P and the clinical significance of corneal sensation]. , 1997, Nippon Ganka Gakkai zasshi.

[49]  H. Colten,et al.  Pulmonary inflammation--a balancing act. , 1997, The New England journal of medicine.

[50]  K. Yamada,et al.  An examination of the close relationship between lymphatic vessels and nerve fibers containing calcitonin gene-related peptide and substance P in rat skin. , 1996, Nagoya journal of medical science.

[51]  N. Frossard,et al.  Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis , 1995, Allergy.

[52]  C. Belmonte,et al.  Neurotrophic influences on corneal epithelial cells. , 1994, Experimental eye research.

[53]  C. Murphy,et al.  Stimulation of epithelial cell growth by the neuropeptide substance P , 1993, Journal of cellular biochemistry.

[54]  S. Nakanishi,et al.  The primary structure and gene organization of human substance P and neuromedin K receptors. , 1992, European journal of biochemistry.

[55]  M. Moskowitz,et al.  Intraneuronal substance P contributes to the severity of experimental arthritis. , 1984, Science.

[56]  J. Folkman,et al.  Tumor growth and neovascularization: an experimental model using the rabbit cornea. , 1974, Journal of the National Cancer Institute.

[57]  C. Pothoulakis,et al.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. , 2014, Physiological reviews.

[58]  D. Azar Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). , 2006, Transactions of the American Ophthalmological Society.

[59]  D. Ganea,et al.  Expression of NK-1 receptor mRNA in murine T lymphocytes. , 1996, Neuroimmunomodulation.

[60]  J. Foreman Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin. , 1987, International archives of allergy and applied immunology.